| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | BIOTECNOLOGÍA | 7.260,025510 | 20/04/2026 | 8,34% | 54,01% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | BIOTECNOLOGÍA | 2.987,520000 | 20/04/2026 | 7,55% | 54,63% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | BIOTECNOLOGÍA | 767,006803 | 20/04/2026 | 8,24% | 51,72% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | BIOTECNOLOGÍA | 460,210000 | 20/04/2026 | 8,49% | 57,83% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | BIOTECNOLOGÍA | 350,204082 | 20/04/2026 | 8,65% | 57,51% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | BIOTECNOLOGÍA | 302,840000 | 20/04/2026 | 7,90% | 57,93% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 2.659,855442 | 20/04/2026 | 8,41% | 54,56% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS C CAP EUR | RVI EMERGENTES | 1.435,630000 | 20/04/2026 | 18,28% | 71,76% | **** |
| CANDRIAM EQUITIES L EMERGING MARKETS C DIS EUR | RVI EMERGENTES | 887,870000 | 20/04/2026 | 18,28% | 59,19% | ** |
| CANDRIAM EQUITIES L EMERGING MARKETS C-H CAP USD | RVI EMERGENTES | 266,454082 | 20/04/2026 | 19,01% | 68,46% | **** |
